We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

SANOFI

Citywest Business Campus, Dublin 24, Ireland
Telephone: +353 1 4035600
Fax: +353 1 4035687
Medical Information e-mail: iemedinfo@sanofi.com
Patient Information Leaflet last updated on medicines.ie: 2/13/2018
PIL TAXOTERE 20 mg/1 ml concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 2/13/2018 and displayed until Current
Reasons for adding or updating:
  • Change to section 6 - date of revision
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - driving and using machines
  • Change to section 4 - possible side effects
Updated on 1/8/2018 and displayed until 2/13/2018
Reasons for adding or updating:
  • Improved presentation of PIL
Updated on 11/30/2017 and displayed until 1/8/2018
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 9/29/2017 and displayed until 11/30/2017
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 6/9/2017 and displayed until 9/29/2017
Reasons for adding or updating:
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 11/2/2016 and displayed until 6/9/2017
Reasons for adding or updating:
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 5/29/2015 and displayed until 11/2/2016
Reasons for adding or updating:
  • Change to side-effects
Updated on 10/29/2014 and displayed until 5/29/2015
Reasons for adding or updating:
  • Change to side-effects
Updated on 4/8/2014 and displayed until 10/29/2014
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 12/13/2013 and displayed until 4/8/2014
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 3/28/2013 and displayed until 12/13/2013
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 8/21/2012 and displayed until 3/28/2013
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 12/17/2010 and displayed until 8/21/2012
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   docetaxel trihydrate